Edition:
United Kingdom

Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

5.40USD
23 Feb 2018
Change (% chg)

$0.41 (+8.22%)
Prev Close
$4.99
Open
$5.60
Day's High
$5.66
Day's Low
$5.21
Volume
8,655
Avg. Vol
3,283
52-wk High
$7.56
52-wk Low
$2.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.11 -0.013
Dec 0.14 -0.037
FY 2016 Jun '16 0.24 -0.077
Dec 0.17 -0.036
 
*Note: Units in Millions ofAustralian Dollars
**Note: Units in Australian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-18 1 4.04 4.04 4.04 0.00
Year Ending Jun-19 1 13.96 13.96 13.96 0.00
Earnings (per share)
Year Ending Jun-18 1 -259.59 -259.59 -259.59 -16.00
Year Ending Jun-19 1 -134.36 -134.36 -134.36 -24.00
Sales and Profit Figures in Australian Dollar (AUD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 83.93 32.90
P/E High - Last 5 Yrs. -- 292.71 45.97
P/E Low - Last 5 Yrs. -- 91.44 24.37
Beta -0.08 0.90 0.89
Price to Sales (TTM) 79.63 110.72 5.77
Price to Book (MRQ) 0.18 13.56 5.41
Price to Tangible Book (MRQ) 2.10 14.02 6.98
Price to Cash Flow (TTM) -- 71.33 23.42
% Owned Institutions 1.59 12.89 2.22

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.66 5.21
Payout Ratio(TTM) -- 15.70 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.57 398.34 9.24
Sales (TTM) vs TTM 1 Yr. Ago -38.66 78.63 5.59
Sales - 5 Yr. Growth Rate -29.68 32.11 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.47 25.10 19.66
EPS (TTM) vs TTM 1 Yr. Ago 55.28 -- --
EPS - 5 Yr. Growth Rate -- 38.95 10.73
Capital Spending - 5 Yr. Growth Rate 63.40 40.24 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.18
Current Ratio (MRQ) 3.62 5.30 2.97
LT Debt to Equity (MRQ) 0.00 22.82 12.22
Total Debt to Equity (MRQ) 0.00 24.47 16.52
Interest Coverage (TTM) -381,217.00 -98.78 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.03 54.70
Gross Margin - 5 Yr. Avg. -- 51.06 52.42
EBITD Margin (TTM) -6,924.99 -- --
EBITD - 5 Yr. Avg -2,506.94 -572.68 10.86
Operating Margin (TTM) -7,495.51 -717.10 4.64
Operating Margin - 5 Yr. Avg. -2,718.78 -594.00 6.26
Pre-Tax Margin (TTM) -4,367.83 -691.66 5.44
Pre-Tax Margin - 5 Yr. Avg. -2,028.72 -597.35 6.60
Net Profit Margin (TTM) -4,288.05 -692.88 1.76
Net Profit Margin - 5 Yr. Avg. -2,018.50 -600.21 2.91
Effective Tax Rate (TTM) -- 22.57 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.19 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,602,130 855,673,508
Net Income/Employee (TTM) -- 2,968,748 100,656,226
Receivable Turnover (TTM) 0.11 20.14 5.78
Inventory Turnover (TTM) -- 2.36 3.35
Asset Turnover (TTM) 0.01 0.39 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -29.88 -1.05 10.98
Return on Assets - 5 Yr. Avg. -34.24 -0.57 12.37
Return on Investment (TTM) -33.03 1.66 14.43
Return on Investment - 5 Yr. Avg. -38.70 2.23 16.18
Return on Equity (TTM) -36.01 2.58 16.13
Return on Equity - 5 Yr. Avg. -39.42 3.13 17.47
  1 Year 3 Year 5 Year
Sales % -38.66 42.12 -29.68
EPS (TTM) % 79.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kazia Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.34%
# of Holders: 6
Total Shares Held: 451,302
3 Mo. Net Change: 373,986
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 1
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.